Tokyo, Japan and Cambridge, UK, 31 October 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) will receive a US$3.75 million milestone payment under the 2019 multi-target Research Collaboration and License Agreement with Genentech, a member of the Roche Group. The discovery-based payment is related to progression of a potential first-in-class project targeting an undisclosed G protein-coupled receptor (“GPCR”). Genentech will now be responsible for further development and commercialization of this potential new medicine.
This milestone is the latest of an ongoing…
They have designed ioCRISPR-Ready Cells to significantly reduce the time investment required to produce gene knockouts and run CRISPR screens in human iPSC-derived cells. READ MORE
CCDC extends its partnership with Orgmento, a Ghanaian software engineering and data sciences company.
The partnership, which started in 2021, has been strengthened by the shared commitment to engineering excellence from both organizations, and has now been extended for a further 3 years.
Software engineering teams from the CCDC and Orgmento will build software to advance structural science.
Cambridge, UK. 31 October 2023
The Cambridge Crystallographic Data Centre (CCDC) announces a three-year extension with partners Orgmento, a software engineering and data sciences company based in…
The October issue of our monthly People Pathways newsletter is now available to read here!
You will have the chance to:
✅ Register for BLSA Careers Conference 2024
✅ Read about and register for our upcoming courses
✅ Attend our next Lunch & Learn for free
✅ Discover our latest member appointments
And more!
Cambridge, UK, October 12, 2023 – Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the appointment of expert advisors Dr. Cassandra Choe-Juliak MD, formerly Chief Medical Officer at Flame Biosciences; Dr. Greg Elson, an expert in end-to-end development of novel antibody-based products with more than 30 years of industry experience; and Samantha Vieira MBA PMP, formerly Chief Operating Officer at Anjarium Biosciences.
Each newly appointed advisor further strengthens…
AMSBIO has published a case study that describes how a team of scientists, led by Dr. Roger Kamm from the Massachusetts Institute of Technology (MIT), has developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).
For one of the most fatal types of MND, amyotrophic lateral sclerosis (ALS), patients have a life expectancy of only 2 to 5 years. Despite widespread research efforts, effective treatments for MNDs remain elusive, largely due to the complex nature of these diseases and a lack of in-depth understanding…
Material manufacturer Xampla has appointed a new chief executive to scale-up the business.
Alexandra French, an experienced chemist with a degree in natural sciences from the University of Cambridge, has joined Xampla to lead it through the next phase of growth.
She has extensive experience after 25 years at specialty chemicals company, Johnson Matthey, where she held a variety of senior leadership, commercial, operation and technical roles, and her most recent role leading operations at AIM listed company, Titon, across the UK, Europe, the US and South Korea.
French will spearhead…
Press release
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director
Edinburgh and Cambridge, UK, 19 October 2023 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director.
Based in the UK and CEO of Cambridge, UK/Cambridge, US based, Bicycle Therapeutics (NASDAQ: BCYC), Kevin brings two decades of biotech and pharma experience to Macomics. In addition to his seat on Bicycle’s board of directors, he is also a non-executive director of Alchemab Therapeutics Ltd.
Kevin has…
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.
As the UK's…
The next UCL SysMIC online course in coding, modelling & data analysis, will start on Monday 6th November 2023.
Participants will become confident in using the Python, R and MATLAB platforms, developing interdisciplinary skills that will make them more effective researchers with the confidence to develop and apply computational techniques in modelling and data analysis to their own work.
Our materials were designed by bio-scientists, for bio-scientists and are focused on biological applications and practical approaches that let participants develop coding and analysis skills while…